Corrigendum: Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
- 1Department of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrücken, Germany
- 2Inflammation Research Center, VIB, Ghent, Belgium
- 3Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
- 4Department of Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany
- 5Institute of Pathology, Medical University of Graz, Graz, Austria
- 6Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria
by Kessler, S. M., Laggai, S., Van Wonterghem, E., Gemperlein, K., Müller, R., Haybaeck, J., et al. (2016) Front. Physiol. 7:147. doi: 10.3389/fphys.2016.00147
Reason for Corrigendum:
In the original article, the name of the third author was mistakenly shortened to Elien van Wonterg. The correct name should be Elien Van Wonterghem instead of Elien Van Wonterg. The authors apologize for this miscommunication.
This error does not change the scientific conclusions of the article in any way.
The original article has been updated.
Original Work: SL performed most of the experiments. EW, RV, and CL performed the hydrodynamic gene delivery. SL and MO planned and performed the cloning. KG and RM performed GC-MS measurements. JH did the histological analysis. SK, SL, and AK planned experiments, analyzed data, and wrote the manuscript. AK designed and directed the study. All authors critically revised the work, approved the final version of the manuscript to be published, and agreed to be accountable for all aspects of the work. Corrigendum: SL, SK, and AK wrote the Corrigendum.
The project was funded, in part, by the Else Kröner-Fresenius-Stiftung (2012_A250 to AK and SK) and the Graduiertenförderung of Saarland University (to SL).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: insulin-like growth factor 2 (IGF2), NASH, hydrodynamic gene delivery, fatty liver, lipid droplets
Citation: Kessler SM, Laggai S, Van Wonterghem E, Gemperlein K, Müller R, Haybaeck J, Vandenbroucke RE, Ogris M, Libert C and Kiemer AK (2016) Corrigendum: Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation. Front. Physiol. 7:328. doi: 10.3389/fphys.2016.00328
Received: 06 July 2016; Accepted: 18 July 2016;
Published: 29 July 2016.
Edited and reviewed by: Steven Dooley, University of Heidelberg, Germany
Copyright © 2016 Kessler, Laggai, Van Wonterghem, Gemperlein, Müller, Haybaeck, Vandenbroucke, Ogris, Libert and Kiemer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alexandra K. Kiemer, email@example.com
†These authors have contributed equally to this work.